Medical News

RSS

Breakthrough discovery could help young girls suffering from rare form of epilepsy

An international team, led by a University of Adelaide genetics expert, has made a breakthrough discovery which is expected to help thousands of young girls worldwide who are suffering from a rare yet debilitating form of epilepsy.

7 Jul 2015

Common arthritis drug could help to treat patients with blood cancers

Scientists at the University of Sheffield have discovered that a common drug given to arthritis sufferers could also help to treat patients with blood cancers.

7 Jul 2015

Celtaxsys receives FDA clearance to begin acebilustat Phase 2 trial in adult CF patients in the US

Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.

7 Jul 2015

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA is pleased to announce it has made a $10,000 contribution to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute in Boston (MA, USA).

From INTEGRA Biosciences 6 Jul 2015

Boehringer Ingelheim LUX-Lung 8 trial reveals afatinib better than erlotinib to treat SCC of the lung

Boehringer Ingelheim today announced The Lancet Oncology has published results from the LUX-Lung 8 trial. LUX-Lung 8 is the largest, prospective Phase III head-to-head trial directly comparing two EGFR-directed treatments.

6 Jul 2015

Healthcare innovations pioneered in the East Midlands to benefit millions of people throughout England

Following an international search, NHS England’s Medical Director Sir Bruce Keogh has today (Monday 6th July) revealed the 17 ‘fellows’ who will be part of the NHS National Innovation Accelerator programme.

6 Jul 2015

VitalPAC clinical decision support system passes 100 million milestone

The system has grown rapidly since its launch in 2005 to become the industry standard product of its type. It is now used in 600 wards across 45 hospitals with over five million sets of observations being collected each month.

6 Jul 2015

Leica DM2500 LED Microscope for clinical laboratories and research applications launched by Leica Microsystems

With the launch of the Leica DM2500 LED, Leica Microsystems completes its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The Leica DM2500 LED is suitable for demanding tasks in clinical laboratories as well as for research applications in microbiology, developmental biology, cytology, zoology, botany, and more.

From Leica Microsystems GmbH 6 Jul 2015

Socioeconomic conditions in early life influence adult's physical activity, shows research

A comprehensive review funded by the UK Medical Research Council has found that a disadvantaged childhood can place adults at risk of not doing enough sports and exercise.

6 Jul 2015

New treatment option available for CLL patients in Manitoba and Saskatchewan

People in Manitoba and Saskatchewan living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new treatment option through the prescription drug insurance plans in both provinces. Earlier this week, GAZYVA (obinutuzumab) in combination with chlorambucil chemotherapy was added to benefits formularies of the Provincial Oncology Drug Programs at CancerCare Manitoba and the Saskatchewan Cancer Agency.

6 Jul 2015

Allergan enters into agreement to acquire Oculeve

Allergan plc, a leading global pharmaceutical company, and Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease, today announced that they have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction.

6 Jul 2015

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).

6 Jul 2015

Zecotek provides shareholders with corporate update on 3D display and 3D printing technologies

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge 3D display and 3D printing technologies.

6 Jul 2015

TSO3 forms wholly owned subsidiary to meet US customer requirements

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced the formation of a wholly owned subsidiary: TSO3 Corporation, structured under the laws of the State of Delaware, and located in the State of South Carolina, USA.

6 Jul 2015

ImmunoCellular, Novella partner to conduct ICT-107 phase 3 registration trial in patients with glioblastoma

ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies.

6 Jul 2015

New CNIT mobile app for Healthcare One Pass launched to provide comprehensive healthcare services

China Information Technology, Inc., a leading provider of integrated cloud-based platform, exchange, and big data solutions in China, today announced that the Company launched its mobile app for Healthcare One Pass, ushering in a new age of accessible healthcare services on mobile devices.

6 Jul 2015

Parents' views on safety and benefits of vaccines have shifted, finds new poll

Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents' views on vaccines became more favorable, according to a new nationally-representative poll.

6 Jul 2015

28th ECNP Congress of the European College of Neuropsychopharmacology to take place in Amsterdam

Europe's largest meeting for the science and treatment of disorders of the brain, the 28th ECNP Congress of the European College of Neuropsychopharmacology will take place at the Amsterdam RAI from 29 August to 1 September 2015.

6 Jul 2015

Researchers unravel mechanisms that enable accumulation of tumour promoting protease in stressed cancer cells

A mechanism beyond the level of gene regulation, which is often the underlying reason for changes in protein levels, does enable the strong accumulation of a tumour promoting protease in stressed cancer cells. The group of BIOSS researcher Prof. Dr. Thomas Reinheckel teamed up with BIOSS investigator Prof. Dr. Sabine Rospert and their colleagues from the University Medical Center Freiburg, Prof. Dr. Elmar Stickeler and Dr. Peter Bronsert, in order to unravel mechanisms by which stress-resistant production of cancer promoting proteins occurs.

6 Jul 2015

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston School of Public Health.

6 Jul 2015

Medical News

Breakthrough discovery could help young girls suffering from rare form of epilepsy

Common arthritis drug could help to treat patients with blood cancers

Celtaxsys receives FDA clearance to begin acebilustat Phase 2 trial in adult CF patients in the US

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

Boehringer Ingelheim LUX-Lung 8 trial reveals afatinib better than erlotinib to treat SCC of the lung

Healthcare innovations pioneered in the East Midlands to benefit millions of people throughout England

VitalPAC clinical decision support system passes 100 million milestone

Leica DM2500 LED Microscope for clinical laboratories and research applications launched by Leica Microsystems

Socioeconomic conditions in early life influence adult's physical activity, shows research

New treatment option available for CLL patients in Manitoba and Saskatchewan

Allergan enters into agreement to acquire Oculeve

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Zecotek provides shareholders with corporate update on 3D display and 3D printing technologies

TSO3 forms wholly owned subsidiary to meet US customer requirements

ImmunoCellular, Novella partner to conduct ICT-107 phase 3 registration trial in patients with glioblastoma

New CNIT mobile app for Healthcare One Pass launched to provide comprehensive healthcare services

Parents' views on safety and benefits of vaccines have shifted, finds new poll

28th ECNP Congress of the European College of Neuropsychopharmacology to take place in Amsterdam

Researchers unravel mechanisms that enable accumulation of tumour promoting protease in stressed cancer cells

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News